Supply Chain

The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic's application to expand the indications for certain pacemakers and defibrillators for patients with heart failure.

Preliminary first quarter 2014 revenue for Sunnyvale, Calif.-based Surgical Intuitive's da Vinci Surgical Systems is expected to be 59 percent lower than first quarter 2013 revenue, falling from $256 million to $106 million, according to a company news release.

The following are medical device company acquisitions that have occurred in the past four weeks, beginning with the most recent.

By 2018, the global cardiovascular information system market is expected to be valued at $232.9 million, growing at a compound annual growth rate of 7.8 percent, according to a Markets and Markets news release.

In late March, the U.S. Food and Drug Administration released a report indicating medical device recalls had increased 97 percent over the last decade.

For providers wondering how much it would cost to improve capacity, Skanska USA's app, Prognos, has them covered.

Minneapolis-based Medtronic has acquired the majority of the shares of Biostar, a distribution company in Istanbul, Turkey.

HealthTrust Purchasing Group partnered with Hackensack (N.J.) University Medical Center to determine savings opportunities surrounding purchased services.

Charlotte, N.C.-based Premier has acquired College Station, Texas-based MEMdata, a technology management and capital equipment planning firm specializing in medical facilities.

The U.S. Food and Drug Administration has approved German pharmaceutical company Boehringer Ingelheim's Pradaxa (dabigatran etexilate) to treat deep venous thrombosis and pulmonary embolism for patients who have been treated with an injectable anticoagulant for five to 10 days, according…